Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Shanxi Taxus Pharma Plans to Acquire California Pharma

publication date: Feb 28, 2014
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shanxi Taxus Pharmaceutical will pay $5 million to acquire an 80%-90% stake in a California therapeutics company. Taxus has not disclosed the name of the acquisition target. However, Taxus says the target is developing regenerative products and a diabetes treatment. Taxus grows yew trees, from which it produces the chemotherapy paclitaxel, a treatment for breast and ovarian cancer. More details....

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...